| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.034 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |